Latest news with #JamesPorter
BBC News
a day ago
- Business
- BBC News
Plan to merge Highland and Aberdeenshire-based machinery rings
Two Scottish farming co-operatives have announced plans to merge their Ringlink Scotland Ltd and Highland Business Services Ltd (HBS) would have a combined membership of more than 4,000 farmers and crofters and an annual turnover of £100m, if the deal goes Kessock-headquartered HBS will ask its members to vote on the plans next month. If approved, the merger could take place on 1 farming, "rings" enable farmers to pool resources such as machinery and workers, and first started taking off in Scotland about 50 years ago. Borders Machinery Ring was the UK's first when it was set up in 1987, and Ringlink Scotland became the second when it was established a year later. 'Reduce costs' The proposed new business would take the Ringlink Scotland name and could involve about 450 workers in would operate in the Highlands, Argyll, Angus and will ask its members to vote on the merger on 11 Scotland said it would retain its offices in Cupar, Coupar Angus, Oldmeldrum and James Porter said: "Both rings have worked closely together over the last few years and the proposed merger is the next logical step forward in the machinery ring concept in the north of Scotland."HBS chairwoman Anne Rae Macdonald the merger would be a "significant step" in the Highland group's added: "The merger will enable the joint business to build on existing resources, help find new opportunities for our farming and crofting businesses, provide on-going support for staff and reduce costs in areas such as administration, computer software and professional fees."There are a number of other rings in the Scotland, and about 30 in total across the the aims of rings are to overcome staff shortages and also help individual farmers avoid having to buy expensive machinery.
BBC News
02-06-2025
- General
- BBC News
Nottingham dealer who mass messaged Ilkeston's addicts jailed
A dealer who was part of a gang supplying drugs from Nottingham to a Derbyshire town has been Porter had been sending out scores of bulk messages to drug users in Ilkeston, in order to sell Class A and B drugs when he came on to the police's radar in raided a number of properties in Wollaton linked to Porter and found drugs, cash, phones, lists of customers, deal bags and weighing scales, as well as designer clothing, knives and an Nottingham Crown Court on Wednesday, the 32-year-old was sentenced to seven years. Porter, of Calderdale in Wollaton, Nottingham, had pleaded guilty to two counts of conspiring to supply Class A drugs, possession with intent to supply cocaine and heroin, and possession of a Class B on his devices showed almost 200 mass messages had been sent to addicts in the his sentencing, PC Jack Shephard said Porter had been "enjoying a lavish lifestyle funded by the sale of drugs" by dealing to "vulnerable people addicted to Class A drugs".
Yahoo
01-04-2025
- Business
- Yahoo
Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
CAMBRIDGE, Mass., April 1, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Stifel 2025 Virtual Targeted Oncology Forum on Tuesday, April 8, 2025, at 2:30 p.m. ET. A live webcast will be available in the Investors section of the company's website at and archived for 30 days following the presentations. About NuvalentNuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs. View original content to download multimedia: SOURCE Nuvalent, Inc.
Yahoo
28-02-2025
- Business
- Yahoo
Nuvalent to Participate in Upcoming March Investor Conferences
CAMBRIDGE, Mass., Feb. 28, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in fireside chats during the following March investor conferences: TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025 at 9:50 a.m. ET in Boston; Leerink Global Healthcare Conference 2025 on Monday, March 10, 2025 at 10:40 a.m. ET in Miami, FL; and, Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 2:30 p.m. ET in Miami, FL. Live webcasts will be available in the Investors section of the company's website at and archived for 30 days following the presentations. About NuvalentNuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs. View original content to download multimedia: SOURCE Nuvalent, Inc.
